Intellect Neurosciences, Inc
  • Home »
  • Investors »
  • Press Releases

Press Releases

  • Email Alerts
  • IR Contacts
  • RSS News Feed
  • Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings
    Feb 14, 2012, 8:35 AM EST
  • Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods to Target Abnormal Tau Protein in Treatment of Alzheimer's disease
    Feb 7, 2012, 8:30 AM EST
  • Intellect Neurosciences Issues Letter to Shareholders
    Feb 2, 2012, 1:44 PM EST
  • Intellect Neurosciences, Inc. to Present at BIO Asia International Conference
    Jan 17, 2012, 9:35 AM EST
  • Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
    Dec 15, 2011, 9:35 AM EST
  • Intellect Neurosciences, Inc. to Present at OneMedForum
    Dec 14, 2011, 9:35 AM EST
  • Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimer's Immunotherapy Programs
    Nov 8, 2011, 9:35 AM EST
  • Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application
    Nov 3, 2011, 9:35 AM EDT
  • Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies
    Oct 26, 2011, 9:35 AM EDT
  • Intellect Neurosciences, Inc. to Present at 10TH Annual BIO Investor Forum
    Oct 19, 2011, 10:00 AM EDT
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Show All

Investors

News / Events
  • Press Releases
  • ILNS in The News
  • Upcoming Events
Company Info
  • Overview
  • Profile
  • Management Team
  • Strategic Relationships
  • Presentations
  • Videos
Shareholder Resources
  • IR Contacts
  • Request Info
  • Email Alerts
  • FAQ
Stock Info
  • Quote
  • Charts
  • Depth / Level 2
  • Historical Quotes
Financial Info
  • Financials
Corporate Governance
  • Board of Directors
  • Governance Documents
Regulatory Info
  • SEC Filings
  • Insiders / Section 16
image description Corporate Video
image descriptionEmail Alerts
  • Home
  • Company Info
    • Overview
    • Management Team
    • Advisory Boards
    • Board of Directors
    • Strategic Partnerships
  • Alzheimer's Disease
    • Facts
    • Glossary of Terms
    • Links
  • Friedrich's Ataxia
    • About FA
  • Platform Technologies
    • ANTISENILIN®
    • RECALL-VAX™
    • CONJUMAB-A
  • Internal Pipeline
  • Media Center
    • Press Releases
    • Videos
    • ILNS in The News
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Shareholder Services
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Regulatory Info
  • Contact
  • Home
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us

© Copyright 2012 Intellect Neurosciences, Inc. All Rights Reserved. Website by Equisolve